均瑶健康: 湖北均瑶大健康饮品股份有限公司第四届监事会第九次会议决议公告

Group 1 - The core point of the announcement is the approval of the company's expected related party transactions for the year 2025, amounting to no more than 119.5 million yuan [1][2] - The supervisory board confirmed that the related party transactions for 2024 were executed legally and adhered to principles of integrity, fairness, and justice, without harming the interests of the company and its shareholders, especially minority shareholders [2] - The proposed related party transactions for 2025 are deemed necessary for the company's normal production and operation, beneficial for the development of its main business, and do not harm the interests of minority shareholders [2] Group 2 - The supervisory board's resolution requires submission to the shareholders' meeting for further approval [2] - The meeting was held on April 1, 2025, with all three supervisors present, and complied with relevant laws and regulations [1] - The voting results for the related party transaction proposal were unanimous in favor, with no votes against or abstentions, although two supervisors recused themselves due to conflicts of interest [2]